Nanobiotix S.A.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Nanobiotix S.A. generated cash of -$12,476,000, which is more than the previous year. Cash used in financing activities reached the amount of $46,771,000 last year. Net change in cash is therefore $33,895,000.
Cash Flow
| 2014 | -8.56M | -1.14M | 37.71M |
|---|---|---|---|
| 2015 | -16.82M | -2.20M | 3.05M |
| 2016 | -18.28M | -444.98K | 22.89M |
| 2017 | -21.03M | -1.46M | 48.53M |
| 2018 | -25.98M | 71K | 14.85M |
| 2019 | -41.16M | -1.45M | 41.48M |
| 2020 | -27.53M | -112K | 111.76M |
| 2021 | -29.87M | -242K | -5.18M |
| 2022 | -37.10M | 138K | -5.65M |
| 2023 | -12.47M | -349K | 46.77M |
NBTX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 41.38M | 83.92M | 119.15M | 35.09M | 36.20M | 47.21M | 21.05M | 17.00M | 32.98M | 4.98M |
Operating activities | ||||||||||
Net income | -39.7M | -57.04M | -47.00M | -33.59M | -50.91M | -30.34M | -26.14M | -21.88M | -17.00M | -9.55M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.51M | 1.5M | 1.56M | 1.75M | 1.76M | 619K | 403.85K | 482.79K | 456.08K | 307.56K |
Stock-based compensation expense | 3.3M | 3.17M | 3.20M | 2.92M | 4.32M | 0 | 2.60M | 1.99M | 1.29M | 252.25K |
| Deferred income tax benefit | 3.3M | 3.17M | 3.20M | 2.92M | 4.32M | 0 | 2.60M | 1.99M | 1.29M | 252.25K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -806K | -101K | 62K | -51K | -85K | 144K | -164.28K | 74.81K | -78.38K | -743 |
Inventories | 0 | -2.90M | 281K | 995K | -2.05M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 8.67M | 2.90M | -281K | -995K | 2.05M | 633K | 785.95K | 788.69K | 1.35M | 0 |
Cash generated by operating activities | -12.47M | -37.10M | -29.87M | -27.53M | -41.16M | -25.98M | -21.03M | -18.28M | -16.82M | -8.56M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -9K | -4K | -16K | 0 | -1.46M | -444.98K | -2.27M | -1.14M |
Investments In Property Plant And Equipment | -328K | -93K | -233K | -107K | -1.44M | -506K | -1.46M | -400.10K | -1.49M | -963.25K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 72.95K | 0 |
Cash generated by investing activities | -349K | 138K | -242K | -112K | -1.45M | 71K | -1.46M | -444.98K | -2.20M | -1.14M |
Financing activities | ||||||||||
Common Stock Issued | 60.15M | 0 | -306K | 113.65M | 29.51M | 59K | 53.14M | 23.16M | 354.8K | 58.46M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.38K | -19.78M |
Repayments of term debt | -3.61M | -4.73M | -3.74M | -250K | 12.43M | -927K | -1.03M | -1.03M | 2.29M | -204.68K |
Cash used in financing activities | 46.77M | -5.65M | -5.18M | 111.76M | 41.48M | 14.85M | 48.53M | 22.89M | 3.05M | 37.71M |
Net Change In Cash | 33.89M | -42.53M | -35.23M | 84.05M | -1.10M | -11.00M | 26.15M | 4.05M | -15.98M | 28.00M |
Cash at end of period | 75.28M | 41.38M | 83.92M | 119.15M | 35.09M | 36.20M | 47.21M | 21.05M | 17.00M | 32.98M |
| Data source | Data source | Data source | Data source |